Gene · 54888
Papers1,406
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,406
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALKBH1 activity in vitro and human cell lines by isotope dilution mass spectrometry. | PLoS One | 2026 | 41941523 | PubTator, text mining | PubMed |
| NSUN2 as an emerging epigenetic regulator in cancer: from biomarker to therapeutic target. | RNA Biol | 2026 | 41937349 | PubTator, text mining | PubMed |
| A Tumor-Targeted tRF Therapeutics Triggers Ovarian Cancer Ferroptosis via Dual Inhibition of System Xc. | Adv Mater | 2026 | 41913348 | PubTator, text mining | PubMed |
| m5C RNA methylation is dysregulated by oncogenic herpesviruses via c-Myc signaling to counteract host antiviral factors. | Nucleic Acids Res | 2026 | 41873763 | PubTator, text mining | PubMed |
| SIRT1 overexpression derived by NSUN2-mediated m5C methylation alleviates tenogenic injury of human tendon-derived stem cells. | Tissue Cell | 2026 | 41864070 | PubTator, text mining | PubMed |
| RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP-9. | Oncol Lett | 2026 | 41858375 | PubTator, text mining | PubMed |
| Histone lactylation-driven feedback loop modulates pyrimidine metabolism to promote oral carcinogenesis. | Cell Death Dis | 2026 | 41857010 | PubTator, text mining | PubMed |
| NSUN2 mediates intestinal stem cell expansion and colorectal tumour initiation via MAPK/ERK signalling. | Cell Death Dis | 2026 | 41856980 | PubTator, text mining | PubMed |
| Epstein-Barr virus drives nasopharyngeal carcinoma metastasis via RNA m5C modification of ICAM-1 mediated by NSUN2 and YBX3. | Cell Death Differ | 2026 | 41851283 | PubTator, text mining | PubMed |
| NSUN2‑mediated epitranscriptomic and ubiquitin modulation of Nipah virus matrix protein reveals a dual-targeting antiviral strategy. | Protein Cell | 2026 | 41849232 | PubTator, text mining | PubMed |
| GPRC5B Identified by m5C meRIP-Seq Suppresses Apoptosis in Osteosarcoma Through NSUN2-Mediated RNA Methylation. | Cancer Sci | 2026 | 41846428 | PubTator, text mining | PubMed |
| Hepatitis B virus promotes hepatocellular carcinoma progression by disrupting NSUN2/YBX1-mediated m5C modification of PTEN mRNA. | Virol Sin | 2026 | 41831785 | PubTator, text mining | PubMed |
| ALYREF-mediated RNA 5-methylcytosine modification promotes laryngeal cancer progression via stabilizing DDX11 mRNA. | Sci Rep | 2026 | 41826389 | PubTator, text mining | PubMed |
| Unveiling m7G modification patterns and causal drivers governing intracranial aneurysm rupture risk through multi-omics validation and m7G-MeRIP-seq profiling. | J Cereb Blood Flow Metab | 2026 | 41816877 | PubTator, text mining | PubMed |
| NSUN2-FOSB reciprocity facilitates leukemogenesis in an m5C-dependent manner by increasing BCL2L1 expression. | Haematologica | 2026 | 41816830 | PubTator, text mining | PubMed |
| Enhancing plant antiviral responses and productivity through the elimination of m5C methyltransferase. | Sci Adv | 2026 | 41811950 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in macrophage function regulation and immunotherapy. | Front Cell Dev Biol | 2026 | 41808933 | PubTator, text mining | PubMed |
| Targeting the NSUN2-DHODH axis reverses ferroptosis resistance and oxaliplatin resistance in colorectal cancer. | Front Pharmacol | 2026 | 41808866 | PubTator, text mining | PubMed |
| Deep learning model and omics screening highlight angiotensinogen as a 5-methylcytosine (m5C) regulated mediator of tumor-microenvironment communication in liver cancer. | Front Immunol | 2026 | 41798911 | PubTator, text mining | PubMed |
| NSUN2 promoted tumor growth and metastatic via m5C-regulation of YAP through ALYREF/YBX1 axis in NSCLC. | Cell Death Dis | 2026 | 41794778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54888/papers?page=3